Početna › Rak mjehura › Wisconsin
Kliničke studije za Rak mjehura u državi Wisconsin
17 studija za Rak mjehura traži sudionike na lokacijama u državi Wisconsin.
Gradovi u državi Wisconsin
- Milwaukee11 studija
- Green Bay6 studija
- Madison4 studija
- Racine4 studija
- Wausau4 studija
- Sheboygan3 studija
- Oshkosh3 studija
- Stevens Point3 studija
Službeni tekst studije (engleski)
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Aspirus Cancer Care-Antigo-Volm Cancer Center, Antigo
- ThedaCare Regional Cancer Center, Appleton
- ThedaCare Regional Medical Center - Appleton, Appleton
- i još 50
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 40 do 75 godina · Oba spola · Ažurirano 2. lis 2026. · NCT05334069Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Duluth Clinic Ashland, Ashland
- Northwest Wisconsin Cancer Center, Ashland
- i još 5
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06770582A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
- UW Health Carbone Cancer Center, Madison
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 2. lis 2026. · NCT06760819Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Invasive Bladder Cancer, BRIGHT Trial
- Ascension Northeast Wisconsin-Saint Elizabeth Cancer Center-Appleton, Appleton
- Ascension Southeast Wisconsin Hospital-Elmbrook Campus-Brookfield, Brookfield
- Ascension Calumet Hospital-Chilton, Chilton
- i još 11
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 1. lis 2026. · NCT07061964Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- Duluth Clinic Ashland, Ashland
- Aurora Cancer Care-Southern Lakes VLCC, Burlington
- Marshfield Medical Center-EC Cancer Center, Eau Claire
- i još 25
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 30. ruj 2026. · NCT03866382ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- ThedaCare Regional Cancer Center, Appleton
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 14. ruj 2026. · NCT05059444The Vanguard Study: Testing a New Way to Screen for Cancer
- Zablocki Veterans Administration Medical Center, Milwaukee
U tijeku regrutacijaZdravi dobrovoljci dobrodošli
Od 45 do 75 godina · Oba spola · Ažurirano 2. ruj 2026. · NCT06995898Dosing Physical Activity Among Older Cancer Survivors Who Experience Chronic Pain: a Micro-randomized Trial
- Froedtert Hospital, Milwaukee
U tijeku regrutacija
Od 65 godina i više · Oba spola · Ažurirano 20. kol 2026. · NCT07227077Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study
- Langlade Hospital and Cancer Center, Antigo
- Cancer Center of Western Wisconsin, New Richmond
- Aspirus Cancer Care - James Beck Cancer Center, Rhinelander
- i još 3
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 18. kol 2026. · NCT07097142A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
- University of Wisconsin- Madison, Madison
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 11. kol 2026. · NCT05592626LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve
- Froedtert Hospital / Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 1/2
Od 18 godina i više · Oba spola · Ažurirano 7. kol 2026. · NCT04752722An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC
- Research Site, Milwaukee
U tijeku regrutacijaFaza 3
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT07720284A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
- Froedtert Hospital/Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaFaza 2
Od 18 godina i više · Oba spola · Ažurirano 22. srp 2026. · NCT04879329Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
- University of Wisconsin-Madison, Madison
U tijeku regrutacija
Od 18 do 88 godina · Oba spola · Ažurirano 2. srp 2026. · NCT06394869Integrated Cancer Repository for Cancer Research
- Bellin Memorial Hospital, Green Bay
U tijeku regrutacijaOpažajna studijaZdravi dobrovoljci dobrodošli
Od 19 do 110 godina · Oba spola · Ažurirano 29. lip 2026. · NCT02012699The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Medical College of Wisconsin, Milwaukee
U tijeku regrutacijaOpažajna studija
Od 18 godina i više · Oba spola · Ažurirano 5. ožu 2026. · NCT04075305SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Milwaukee
U tijeku regrutacijaOpažajna studija
Sve dobne skupine · Oba spola · Ažurirano 28. lis 2025. · NCT03452774Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.